Amedisys Inc (STU:ADY)
€ 87 0 (0%) Market Cap: 2.90 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.87 GF Score: 85/100

Amedisys Inc at Raymond James Institutional Investors Conference (Virtual) Transcript

Mar 03, 2021 / 02:10PM GMT
Release Date Price: €200 (-6.54%)
John Wilson Ransom
Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research

All right. Good morning, everyone. Welcome to the last Virtual Day of the Raymond James Institutional Investor Conference. Here for a repeat performance, we're delighted to have the team from Amedisys, and I would note, we've got a full team on the field. We've got Nick and Paul and Scott and Chris. And the company is just coming off of a fourth quarter earnings report and a guide. So there's lots to get to.

So what I would -- and this is a fireside chat. If you have questions, you can e-mail me at [email protected], where you can hit the question dialogue, I believe, in the upper left of the box.

Questions & Answers

John Wilson Ransom
Raymond James & Associates, Inc., Research Division - MD of Equity Research & Director of Healthcare Research

So without any further preamble. Just wanted to kind of set -- let's take a step back in the way back machine. And Wall Street, and I was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot